https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Weight Loss With Subcutaneous Semaglutide Versus Other Glucagon Like Peptide-1 Receptor Agonists In Type 2 Diabetes: A Systematic Review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51280 Wed 20 Sep 2023 11:45:13 AEST ]]> Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27041 Wed 11 Apr 2018 16:32:14 AEST ]]> Serum testosterone levels correlate with haemoglobin in middle-aged and older men https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7104 Sat 24 Mar 2018 08:34:08 AEDT ]]> Enrolment of patients to clinical trials in haematological cancer in New South Wales: current status, perceived barriers and opportunities for improvement https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10183 Sat 24 Mar 2018 08:12:28 AEDT ]]> Individualised medicine: why we need Bayesian dosing https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30694 Mon 23 Sep 2019 13:58:52 AEST ]]> Do medical oncology patients and their support persons agree about end of life issues? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30021 Fri 10 Mar 2023 18:45:00 AEDT ]]>